Shanghai Cell Therapy Group Co.,Ltd
Shanghai Cell Therapy Group Co.,Ltd
Explore linked clinical trials.8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Antibody-armored Dendritic Cell in Patients With Solid Tumors | Adjuvant Therapy; Solid Cancers | Recruiting | Phase 1 | 2026-03-18 | NCT07479667 | |
| An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, autoimmune disease, blood coagulation disease, blood platelet disease, connective tissue disorder, hematologic disorder, hemorrhagic disease, immune system disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, purpura, systemic lupus erythematosus, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Recruiting | Early phase 1 | 2025-09-16 | NCT07174843 | |
| Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors | Solid Tumor Cancer | Recruiting | Phase 1 / Phase 2 | 2025-08-28 | NCT07146672 | |
| A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL) | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Early phase 1 | 2025-08-21 | NCT06446128 | |
| A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma | Blood Protein Disorders, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Early phase 1 | 2024-12-13 | NCT06732232 | |
| An Exploratory Study by Fast CAR T Cells | Solid Tumor | Recruiting | Early phase 1 | 2024-03-25 | NCT06327997 | |
| An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells | Solid Tumor | Recruiting | Early phase 1 | 2024-02-08 | NCT06249256 | |
| Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors | Solid Tumor | Recruiting | Early phase 1 | 2024-02-08 | NCT06248697 |